SCHEMBL30296367

SCHEMBL30296367

COCc1ccc(-c2cc(F)c(N)cc2Cl)cn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 2/20 0.44
PIK3CB P42338 2/20 0.44
PIK3CD O00329 1/20 0.44
PI4KA P42356 1/20 0.44
PI4KB Q9UBF8 1/20 0.44
FYN P06241 2/20 0.41
MAOA P21397 1/20 0.38
ATM Q13315 10/20 0.38
KCNH2 Q12809 9/20 0.38
KDR P35968 2/20 0.37
MTOR P42345 1/20 0.37
PIK3CG P48736 1/20 0.37
PRKDC P78527 1/20 0.37
MAP4K1 Q92918 1/20 0.36
MAPT P10636 1/20 0.35
STIM1 Q13586 1/20 0.35
ORAI1 Q96D31 1/20 0.35
DYRK1A Q13627 1/20 0.35
S1PR4 O95977 1/20 0.34
HDAC1 Q13547 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30296737 0.82 EPHB4 (0.36) FYNKCNH2DYRK1AS1PR4HDAC1
SCHEMBL31207379 0.81 STIM1 (0.35) PIK3CDFYNSTIM1ORAI1
SCHEMBL26457473 0.80 PRKAG1 (0.49) PIK3CAPIK3CBPIK3CDPI4KAPI4KB
SCHEMBL30296601 0.80 PRKAG1 (0.49) PIK3CAPIK3CBPIK3CDPI4KAPI4KB
SCHEMBL30296539 0.80 PIK3CA (0.46) PIK3CAPIK3CBPIK3CDPI4KAPI4KB
SCHEMBL30296556 0.78 PIK3CA (0.43) PIK3CAPIK3CBPIK3CDPI4KAPI4KB
SCHEMBL26458701 0.78 PIK3CA (0.43) PIK3CAPIK3CBPIK3CDPI4KAPI4KB
SCHEMBL30296380 0.78 CYP11B2 (0.44) PIK3CDFYNSTIM1ORAI1
SCHEMBL26456924 0.78 CYP11B2 (0.44) PIK3CDFYNSTIM1ORAI1
SCHEMBL31207371 0.76 PRKAG1 (0.36) PIK3CAPIK3CBPIK3CDPI4KAPI4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240368173-A1 TRICYCLIC GPR65 MODULATORS Pathios Therapeutics Limited (GB) 2024-11-07 US disclosed
EP-4419203-A1 TRICYCLIC GPR65 MODULATORS Pathios Therapeutics Limited (GB) 2024-08-28 EP disclosed
CN-118451080-A Tricyclic GPR65 modulators 帕蒂奥斯治疗有限公司 2024-08-06 CN disclosed
WO-2023067322-A1 TRICYCLIC GPR65 MODULATORS Pathios Therapeutics Limited (GB) 2023-04-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240368173-A1 TRICYCLIC GPR65 MODULATORS GPR65, GPR3, NR1H2 PIK3CA 3336/4885PIK3CB 3333/4885PIK3CD 3477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.